September 18th 2025
The FDA approved Bosaya and Aukelso, biosimilars of Prolia and Xgeva, respectively, for the treatment of solid tumors, like breast and prostate cancer.
September 17th 2025
September 16th 2025
September 15th 2025
September 15th 2025
September 11th 2025
September 10th 2025
September 10th 2025
July 13th 2025